Sumer Jacquelyn L (CIK 0001844824)

Latest company ownership

CGEM - Cullinan Therapeutics, Inc.

Role: Chief Legal Officer

Shares held

136,895

Last filed at

Feb 27, 2025

Confidence Score

31.8

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 18, 2025	Dec 19, 2025	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	26.3	-3,480	-2.51%	✗	$33.7K
Feb 25, 2025	Feb 27, 2025	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	26.3	-3,756	-2.67%	✗	$32K
Dec 18, 2024	Dec 20, 2024	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	26.3	-3,482	-3.70%	✗	$39.7K
Dec 21, 2023	Dec 22, 2023	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	26.3	-1,400	-3.07%	✗	$11.9K
Dec 18, 2023	Dec 20, 2023	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	37.5	-290	-0.63%	✗	$2.4K
Jun 20, 2023	Jun 21, 2023	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	37.5	-291	-0.63%	✗	$3.8K
May 18, 2023	May 19, 2023	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	37.5	-291	-0.63%	✗	$2.5K
Apr 18, 2023	Apr 20, 2023	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	37.5	-290	-0.62%	✗	$3.1K
Mar 20, 2023	Mar 27, 2023	Cullinan Therapeutics, Inc.	Chief Legal Officer	Sell	37.5	-305	-0.65%	✗	$3.5K